FDA approval of cangrelor powder for intravenous use; this is a regulatory action record that does not contain clinical trial data or efficacy evidence.
Reported
Approval date2026-06-04
Dose formulation50 MG/VIAL
RouteINTRAVENOUS
Loading
Drug or technology
1 development in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
FDA approval of cangrelor powder for intravenous use; this is a regulatory action record that does not contain clinical trial data or efficacy evidence.